Divisions
Taking Care of Your Health, Our Core Divisions
01
Welluate Nutrition
Welluate Nutrition is where nutritional science meets innovation. As the advanced nutrition division, we are dedicated to creating Enhanced Active Nutrition Ingredients (ANIs) that redefine what is possible in modern nutraceuticals. Every formulation is designed to unlock the full potential of bioactive ingredients through precision engineering, scientific excellence, and breakthrough formulation technologies.
Powered by our proprietary ANIs, we combine clinically researched bioactive compounds, advanced delivery systems, and evidence based formulation strategies to enhance stability, absorption, bioavailability, and biological performance. The result is a new generation of nutritional innovations that deliver exceptional quality, superior efficacy, and measurable outcomes.
Our portfolio features proprietary technologies including ZWITTERIONIC EPA DHA™, MULTIPHASIC COLLAGEN™, and SYNBIOTIC IMMUNO CULTURE™, each developed to overcome the limitations of conventional nutraceuticals while setting new standards for performance, consistency, and scientific credibility.
At Welluate Nutrition, we believe the future of health begins with better ingredients. Through ANIs, we are transforming active nutrition into a new era of intelligent, precision engineered solutions where every ingredient is purposefully designed, every formulation is scientifically validated, and every innovation is created to elevate human health beyond expectations.
02
Bioincro RxLabs
Bioincro RxLabs is the pharmaceutical innovation division of Bioincro, dedicated to discovering, developing, and translating next generation therapeutics that address the world's most pressing unmet medical needs. By integrating cutting edge science, translational research, and precision medicine, we accelerate the journey from scientific discovery to transformative patient care.
Our expertise spans pharmaceutical research, drug development, formulation science, clinical strategy, regulatory affairs, and commercialization. Through strong collaborations with clinicians, researchers, academic institutions, healthcare organizations, and industry partners, we build robust development pathways that deliver scientific excellence with global regulatory confidence.
Every Bioincro RxLabs programme is guided by rigorous scientific validation, uncompromising quality standards, and a commitment to innovation. From early stage discovery and preclinical development to clinical research, regulatory approval, and market access, we deliver integrated pharmaceutical solutions designed to improve patient outcomes and advance the future of medicine.
At Bioincro RxLabs, we believe every breakthrough begins with a bold scientific question. Our mission is to transform pioneering research into safe, effective, and accessible therapies that redefine the standards of modern healthcare and create lasting impact for patients worldwide.
03
MedcommonAis PGx Testing
MedCommonAIS Precision Genomics is transforming the future of medicine through the power of pharmacogenomics, artificial intelligence, and precision healthcare. Our mission is to eliminate the uncertainty of prescribing by enabling truly individualized treatment decisions based on each person's unique genetic blueprint.
Harnessing advanced genomic technologies, AI driven interpretation, and clinically validated scientific evidence, our Precision Genomics platform empowers healthcare professionals with actionable insights that optimize drug selection, dosing, efficacy, and safety. By understanding how an individual's genes influence medication response, we help reduce adverse drug reactions, improve therapeutic outcomes, and accelerate the path to effective treatment.
More than a diagnostic service, MedCommonAIS represents a new paradigm in precision medicine where genomics becomes an integral part of everyday clinical care. Every report is designed to transform complex genetic data into clear, clinically meaningful recommendations that support confident decision making across multiple therapeutic areas.
At MedCommonAIS, we envision a future where every prescription is informed by science, every treatment is personalized, and every patient receives the right medicine, at the right dose, at the right time. By uniting genomics, artificial intelligence, and clinical innovation, we are redefining the standard of care and shaping the next generation of healthcare.
Facts and Figures
We’re good with numbers
6
Scientific and Business years of Experience
56
Expert Scientists and Industry Leaders
100K+
Patients Every Year
2
International Collaborations
About Us
Founded on the principles of scientific excellence and entrepreneurial spirit, Bioincro India LLP serves as the holding entity for our diverse life sciences ventures. Our collaborative approach integrates research, technology, and quality management to deliver solutions that empower healthier lives.
Our Vision: To be a leading innovation-driven life sciences group that shapes the future of health.
Our Mission: To develop trusted products and services that improve wellbeing through science and precision.
Our Core Values
Why Us ?
We leverage the latest advancements in biotechnology, digital health, and automation to develop solutions that address tomorrow’s health challenges today.
Next-Generation Innovation
Our operations are built on a foundation of robust Quality Management Systems, comprehensive regulatory adherence, and a relentless commitment to ethical business practices.
Unwavering Compliance
Every process at Bioincro adheres to strict international standards, ensuring reliability, safety, and world-class results you can trust.
Global Best Practices
Our Scientific Partner
United in Excellence: Showcasing
Our Scientific partner
All breakthrough research and patent-protected innovations at Bioincro India LLP are powered by our principal scientific partner, Kwatra Sciences. From ideation and laboratory discovery to clinical trial design and global patent filings, Kwatra Sciences is the engine behind our exclusive technologies, formulations, and regulatory dossiers. This partnership ensures every Bioincro product stands on the pillars of scientific excellence, robust clinical evidence, and unmatched intellectual property, keeping us ahead in the rapidly evolving world of healthcare and life sciences.
OUR TEAM
Ribhav Bhatia
Co-Founder and CEO
Visionary leader driving Bioincro’s growth and innovation, passionate about transforming health with smart, scalable solutions.
Dr. Bharat Kwatra
Founder, Kwatra Sciences
Renowned scientist and biotech innovator powering Bioincro with patented research and a relentless drive for excellence.